Sanofi India Q1 net profit down 14% as revenue declines amid partnership transition

Sanofi India Ltd stated that in the domestic market, its insulin portfolio delivered strong performance for the second consecutive quarter. Shares of Sanofi India Ltd ended at ₹3,469, up by ₹35.95, or 1.05%, on the BSE today, April 28.

Leave a Reply

Your email address will not be published. Required fields are marked *